PharmaShots | Incisive News in 3 Shots

Subscribe Now

SPMS

EMD Serono's Mavenclad (Cladribine) Receives FDA's Approval for RRMS and SPMS in Adults

EMD Serono's Mavenclad (Cladribine) Receives FDA's Approval for RRMS and SPMS in Adults

March 29, 2019

Novartis' Mayzent (siponimod) Receives FDA's Approval for Patients with Secondary Progressive Multiple Sclerosis (SPMS)

Novartis' Mayzent (siponimod) Receives FDA's Approval for Patients with Secondary Progressive Multiple Sclerosis (SPMS)

March 27, 2019

Novartis Announces Acceptance of its Novel Siponimod (BAF312) by the US FDA and EMA

Novartis Announces Acceptance of its Novel Siponimod (BAF312) by the US FDA and EMA

October 8, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us